Open Letter Regarding Cepheid Pricing of the GeneXpert Machines and Cartridges for High-Burden Settings in the Public and Private Sectors
16 April 2012
Open Letters
- previous post: Open Letter to the Medicines Control Council and Ministry of Health on Urgent Need for Compassionate Use of Bedaquiline for XDR-TB and Pre-XDR-TB in South Africa
- next post: Letters to Otsuka, Janssen Pharmaceutical Companies of Johnson & Johnson, Food and Drug Administration and European Medicines Agency on Delamanid and Bedaquiline and Replies